Mechanistic study of TGF-beta-dependent control of gut-resident memory T cells

TGF-β依赖性控制肠道驻留记忆T细胞的机制研究

基本信息

  • 批准号:
    9923521
  • 负责人:
  • 金额:
    $ 37.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-23 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary Infectious diseases pose a significant public health burden, accounting for nearly one-fifth of deaths globally per annum. Most infections are initiated from a restricted mucosal tissue, such as the intestine. To fight intestinal infections, gut-resident immune cells are superior to circulating ones. There is a surge of recent interest in tissue-resident memory T (TRM) cells that have been shown to be a critical adaptive immune component of mucosal immunity. These cells have been flagged as an ideal cell population to be generated in T cell-based vaccines. However, the factors involved in the differentiation and maintenance of gut TRM cells remain poorly defined. Distinct from other T cell populations in the periphery, gut TRM cells harbor a unique transcription network. We propose that simultaneously suppressing the transcription factor Eomes and inducing the transcription factor Runx3 are required for the proper differentiation and maintenance of gut TRM cells following acute infections. Based on our previous findings, we hypothesize that TGF-β mediates TRM cell differentiation and maintenance in the gut through controlling Eomes- and Runx3-dependent transcription programs. Eomes and Runx3 are relatively independent nodules downstream of TGF-β signaling in gut TRM cells. Using different genetic models (conditional and inducible knockout mice that specifically delete TGF-β receptor on T cells, and TGF-β receptor/Eomes double conditional knockout mice in T cells), three major questions will be addressed: 1) When do gut TRM precursor or gut TRM cells receive TGF-β signaling? Whether continuous TGF-β signaling is required for the maintenance of gut TRM cells? What is the transcription program maintained by TGF-β signaling in gut TRM cells? 2) What is the function of TGF-β-dependent down-regulation of transcription factor Eomes in the differentiation and maintenance of gut TRM cells? What is the TGF-β-dependent transcription program that is prevented by Eomes in gut TRM cells? 3) What are the functions of TGF-β dependent induction of transcription factor Runx3? Whether Eomes and Runx3 together control the majority of TGF-β-dependent transcription program in gut TRM cells? The results from these studies will elucidate the transcription program underlying TGF-β-controlled differentiation and maintenance of gut TRM cells. These studies will substantially further our understanding of gut TRM cell biology and lay the basis for future translational works.
项目摘要 传染病构成了重大的公共卫生负担,占全球死亡人数的近五分之一 每年。大多数感染是从限制性粘膜组织,如肠道开始的。打 肠道感染,肠道驻留免疫细胞上级循环的。最近, 对组织驻留记忆T(TRM)细胞的兴趣已被证明是一种关键的适应性免疫 粘膜免疫的组成部分。这些细胞被标记为理想的细胞群, T细胞疫苗然而,参与肠TRM细胞分化和维持的因素 定义不明确。 与外周中的其他T细胞群体不同,肠道TRM细胞具有独特的转录网络。我们 提出同时抑制转录因子Eomes和诱导转录因子 Runx 3是急性感染后肠道TRM细胞正确分化和维持所必需的。 基于我们以前的研究结果,我们假设TGF-β介导TRM细胞的分化和维持, 通过控制Eomes和Runx 3依赖的转录程序在肠道中。Eomes和Runx 3是 肠TRM细胞中TGF-β信号传导下游的相对独立的结节。使用不同的基因模型 (特异性缺失T细胞上的TGF-β受体的条件性和诱导性敲除小鼠,以及特异性缺失TGF-β受体的小鼠) 受体/Eomes双条件性敲除小鼠),将解决三个主要问题: 1)肠道TRM前体或肠道TRM细胞何时接受TGF-β信号传导?是否连续TGF-β 信号是维持肠道TRM细胞所必需的?什么是转录程序维护 通过肠道TRM细胞中的TGF-β信号传导? 2)TGF-β依赖性下调转录因子Eomes在肿瘤细胞中的作用是什么? 肠TRM细胞的分化和维持?什么是TGF-β依赖的转录程序 被肠道TRM细胞中的Eomes阻止的 3)TGF-β依赖性诱导转录因子Runx 3的功能是什么?无论Eomes 和Runx 3共同控制肠道TRM细胞中大部分TGF-β依赖性转录程序? 这些研究的结果将阐明TGF-β调控的转录程序。 肠TRM细胞的分化和维持。这些研究将大大加深我们对 消化TRM细胞生物学,并为未来的翻译工作奠定基础。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tissue-Specific Control of Tissue-Resident Memory T Cells.
  • DOI:
    10.1615/critrevimmunol.2018025653
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    1.3
  • 作者:
    Liu Y;Ma C;Zhang N
  • 通讯作者:
    Zhang N
TGF-β Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nu Zhang其他文献

Nu Zhang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nu Zhang', 18)}}的其他基金

Targeting lymphoid tissue residency to boost tumor immunotherapies
靶向淋巴组织驻留以促进肿瘤免疫治疗
  • 批准号:
    10481357
  • 财政年份:
    2022
  • 资助金额:
    $ 37.57万
  • 项目类别:
Mechanistic study of TGF-beta-dependent control of gut-resident memory T cells
TGF-β依赖性控制肠道驻留记忆T细胞的机制研究
  • 批准号:
    9276608
  • 财政年份:
    2016
  • 资助金额:
    $ 37.57万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.57万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了